Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Organoid and Spheroid Market Trends and Forecast
3.3: Global Organoid and Spheroid Market by Type
3.3.1: Organoids
3.3.1.1: By Product Type
3.3.1.1.1: Neural Organoids
3.3.1.1.2: Hepatic Organoids
3.3.1.1.3: Intestinal Organoids
3.3.1.1.4: Other Organoids
3.3.1.2: By Method
3.3.1.2.1: General Submerged Method for Organoid Culture
3.3.1.2.2: Crypt Organoid Culture Techniques
3.3.1.2.3: Air Liquid Interface (ALI) Method for Organoid Culture
3.3.1.2.4: Clonal Organoids from Lgr5+ Cells
3.3.1.2.5: Brain and Retina Organoid Formation Protocol
3.3.1.3: By Source
3.3.1.3.1: Primary Tissues
3.3.1.3.2: Stem Cells
3.3.2: Spheroids
3.3.2.1: By Product Type
3.3.2.1.1: Multicellular Tumor Spheroids (MCTS)
3.3.2.1.2: Neurospheres
3.3.2.1.3: Mammospheres
3.3.2.1.4: Hepatospheres
3.3.2.1.5: Embryoid Bodies
3.3.2.2: By Method
3.3.2.2.1: Micropatterned Plates
3.3.2.2.2: Low Cell Attachment Plates
3.3.2.2.3: Hanging Drop Method
3.3.2.2.4: Others
3.3.2.3: By Source
3.3.2.3.1: Cell Line
3.3.2.3.2: Primary Cell
3.3.2.3.3: iPSCs (Induced Pluripotent Stem Cells) Derived Cells
3.4: Global Organoid and Spheroid Market by Application
3.4.1: Developmental Biology
3.4.2: Personalized Medicine
3.4.3: Regenerative Medicine
3.4.4: Disease Pathology Studies
3.4.5: Drug Toxicity & Efficacy Testing
3.5: Global Organoid and Spheroid Market by End Use
3.5.1: Biotechnology and Pharmaceutical Industries
3.5.2: Academic & Research Institutes
3.5.3: Hospitals and Diagnostic Centers
4. Market Trends and Forecast Analysis by Region
4.1: Global Organoid and Spheroid Market by Region
4.2: North American Organoid and Spheroid Market
4.2.1: Market by Type: Organoids and Spheroids
4.2.2: Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.2.3: Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.2.4: The United States Organoid and Spheroid Market
4.2.5: The Canadian Organoid and Spheroid Market
4.2.6: The Mexican Organoid and Spheroid Market
4.3: European Organoid and Spheroid Market
4.3.1: Market by Type: Organoids and Spheroids
4.3.2: Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.3.3: Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.3.4: The Organoid and Spheroid Market of United Kingdom
4.3.5: The German Organoid and Spheroid Market
4.3.6: The French Organoid and Spheroid Market
4.4: APAC Organoid and Spheroid Market
4.4.1: Market by Type: Organoids and Spheroids
4.4.2: Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.4.3: Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.4.4: The Chinese Organoid and Spheroid Market
4.4.5: The Indian Organoid and Spheroid Market
4.4.6: The Japanese Organoid and Spheroid Market
4.5: ROW Organoid and Spheroid Market
4.5.1: Market by Type: Organoids and Spheroids
4.5.2: Market by Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, and Drug Toxicity & Efficacy Testing
4.5.3: Market by End Use: Biotechnology and Pharmaceutical Industries, Academic & Research Institutes, and Hospitals and Diagnostic Centers
4.5.4: Brazilian Organoid and Spheroid Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Organoid and Spheroid Market by Type
7.1.2: Growth Opportunities for the Global Organoid and Spheroid Market by Application
7.1.3: Growth Opportunities for the Global Organoid and Spheroid Market by End Use
7.1.4: Growth Opportunities for the Global Organoid and Spheroid Market by Region
7.2: Emerging Trends in the Global Organoid and Spheroid Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Organoid and Spheroid Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Organoid and Spheroid Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: 3D Biomatrix
8.2: 3D Biotek LLC
8.3: AMS Biotechnology Ltd.
8.4: ATCC
8.5: Cellesce Ltd
8.6: Corning Incorporated
8.7: Greiner Bio-One
8.8: Hubrecht Organoid Technology (HUB)
8.9: PerkinElmer
8.10: Kuraray